The global Liver Disease Diagnostics market is one of the fasting growing markets across the world. This research report contains in-depth information on all the statistics and facts & figures related to the Liver Disease Diagnostics market. The business strategies of all the key business players, sales volume data, growth opportunities and other important data have been covered in through detail. This report also provides SWOT analysis, risk analysis, growth analysis, investment analysis and regional analysis. Abbott Laboratories, F. Hoffmann-La Roche AG, Randox Laboratories, Boston Scientific Corporation, Siemens Healthineers AG and more - all the leading players operating in the global Liver Disease Diagnostics market have been profiled in this research report.
With the help of this research report, you will get key information on the upcoming challenges, emerging opportunities, business investments and recent developments in the Liver Disease Diagnostics market. You will also have access to the most important facts & figures that you can utilize for your investment purpose. You also get PEST analysis, SWOT analysis, and Porter’s Five Forces analysis. You get a detailed and fully prepared report on the Liver Disease Diagnostics market.
Global Liver Disease Diagnostics Market is valued approximately at USD 29.3 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2020-2027. Liver Disease Diagnostics is the detecting of the cause and extent of liver disease and it further includes the treatment process. It consists of blood tests, imaging tests, checking a tissue sample, treatment method and clinical trials. Factors such as growing geriatric population and rising prevalence of acute and chronic liver diseases will increase the demand for liver disease diagnostic market. For instance, according to the World Health Organization (WHO), the total new cases of liver cancer that were reported in 2018 were 841,080 and an estimated 781, 631 people died due to liver cancer, globally. Moreover, increasing incidences of end stage liver failure due to rising heavy alcohol consumption, growing prevalence of obesity and the metabolic syndrome are some of the major factors which can upsurge the growth of global organ care system for liver. For instance: According to Statista, alcohol consumption in India was 5.4 billion liters in 2016 and is estimated to reach about 6.5 billion liters by 2020. Also, as per
Summary
Health Statistics, the number of U.S. adults diagnosed with any sort of liver disease was 3.27 million in 2013 and which rose to 4.5 million adults in 2018. However, the stringent government regulations, high cost incurred in drug R&D and side effects associated with medication are some factors restraining the growth of global Liver Disease Diagnostics market during the forecast period.
The regional analysis of global Liver Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the the fast adoption of new technology, high investments in R&D and presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.
Major market player included in this report are:
Abbott Laboratories
F. Hoffmann-La Roche AG
Randox Laboratories
Boston Scientific Corporation
Siemens Healthineers AG
BioMérieux
Quest Diagnostics
Biosino Bio-technology
Horiba, Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diagnosis Technique:
Laboratory Tests
Imaging
Endoscopy
Biopsy
Others
By End-Use:
Hospitals
Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Liver Disease Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Market Research Port provides research reports that are competitively priced for you. So, Get in touch with us today for the latest report on the Liver Disease Diagnostics market.
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.Liver Disease Diagnostics Market, by Region, 2018-2027 (USD Billion)
1.2.2.Liver Disease Diagnostics Market, by Diagnosis Technique, 2018-2027 (USD Billion)
1.2.3.Liver Disease Diagnostics Market, by End-Use, 2018-2027 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Liver Disease Diagnostics Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Scope of the Study
2.2.2.Industry Evolution
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Liver Disease Diagnostics Market Dynamics
3.1.Liver Disease Diagnostics Market Impact Analysis (2018-2027)
3.1.1.Market Drivers
3.1.2.Market Challenges
3.1.3.Market Opportunities
Chapter 4.Global Liver Disease Diagnostics Market Industry Analysis
4.1.Porter’s 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.PEST Analysis
4.2.1.Political
4.2.2.Economical
4.2.3.Social
4.2.4.Technological
4.3.Investment Adoption Model
4.4.Analyst Recommendation & Conclusion
Chapter 5.Global Liver Disease Diagnostics Market, by Diagnosis Technique
5.1.Market Snapshot
5.2.Global Liver Disease Diagnostics Market by Diagnosis Technique, Performance - Potential Analysis
5.3.Global Liver Disease Diagnostics Market Estimates & Forecasts by Diagnosis Technique 2017-2027 (USD Billion)
5.4.Liver Disease Diagnostics Market, Sub Segment Analysis
5.4.1.Laboratory Tests
5.4.2.Imaging
5.4.3.Endoscopy
5.4.4.Biopsy
5.4.5.Others
Chapter 6.Global Liver Disease Diagnostics Market, by End-Use
6.1.Market Snapshot
6.2.Global Liver Disease Diagnostics Market by End-Use, Performance - Potential Analysis
6.3.Global Liver Disease Diagnostics Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
6.4.Liver Disease Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2.Laboratories
6.4.3.Others
Chapter 7.Global Liver Disease Diagnostics Market, Regional Analysis
7.1.Liver Disease Diagnostics Market, Regional Market Snapshot
7.2.North America Liver Disease Diagnostics Market
7.2.1.U.S. Liver Disease Diagnostics Market
7.2.1.1. Diagnosis Technique breakdown estimates & forecasts, 2017-2027
7.2.1.2.End-Use breakdown estimates & forecasts, 2017-2027
7.2.2.Canada Liver Disease Diagnostics Market
7.3.Europe Liver Disease Diagnostics Market Snapshot
7.3.1.U.K. Liver Disease Diagnostics Market
7.3.2.Germany Liver Disease Diagnostics Market
7.3.3.France Liver Disease Diagnostics Market
7.3.4.Spain Liver Disease Diagnostics Market
7.3.5.Italy Liver Disease Diagnostics Market
7.3.6.Rest of Europe Liver Disease Diagnostics Market
7.4.Asia-Pacific Liver Disease Diagnostics Market Snapshot
7.4.1.China Liver Disease Diagnostics Market
7.4.2.India Liver Disease Diagnostics Market
7.4.3.Japan Liver Disease Diagnostics Market
7.4.4.Australia Liver Disease Diagnostics Market
7.4.5.South Korea Liver Disease Diagnostics Market
7.4.6.Rest of Asia Pacific Liver Disease Diagnostics Market
7.5.Latin America Liver Disease Diagnostics Market Snapshot
7.5.1.Brazil Liver Disease Diagnostics Market
7.5.2.Mexico Liver Disease Diagnostics Market
7.6.Rest of The World Liver Disease Diagnostics Market
Chapter 8.Competitive Intelligence
8.1.Top Market Strategies
8.2.Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1.Key Information
8.2.1.2.Overview
8.2.1.3.Financial (Subject to Data Availability)
8.2.1.4.Product Summary
8.2.1.5.Recent Developments
8.2.2. F.Hoffmann-La Roche AG
8.2.3.Randox Laboratories
8.2.4.Boston Scientific Corporation
8.2.5.Siemens Healthineers AG
8.2.6.BioMérieux
8.2.7.Quest Diagnostics
8.2.8.Biosino Bio-technology
8.2.9.Horiba, Ltd.
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.2.Research Attributes
9.3.Research Assumption
